Literature DB >> 27079373

Ndufs4 related Leigh syndrome: A case report and review of the literature.

Juan Darío Ortigoza-Escobar1, Alfonso Oyarzabal2, Raquel Montero3, Rafael Artuch4, Cristina Jou5, Cecilia Jiménez5, Laura Gort6, Paz Briones7, Jordi Muchart8, Ester López-Gallardo9, Sonia Emperador9, Eduardo Ruiz Pesini9, Julio Montoya9, Belén Pérez2, Pilar Rodríguez-Pombo2, Belén Pérez-Dueñas10.   

Abstract

The genetic causes of Leigh syndrome are heterogeneous, with a poor correlation between the phenotype and genotype. Here, we present a patient with an NDUFS4 mutation to expand the clinical and biochemical spectrum of the disease. A combined defect in the CoQ, PDH and RCC activities in our patient was due to an inappropriate assembly of the RCC complex I (CI), which was confirmed using Blue-Native polyacrylamide gel electrophoresis (BN-PAGE) analysis. Targeted exome sequencing analysis allowed for the genetic diagnosis of this patient. We reviewed 198 patients with 24 different genetic defects causing RCC I deficiency and compared them to 22 NDUFS4 patients. We concluded that NDUFS4-related Leigh syndrome is invariably linked to an early onset severe phenotype that results in early death. Some data, including the clinical phenotype, neuroimaging and biochemical findings, can guide the genetic study in patients with RCC I deficiency.
Copyright © 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Keywords:  BN-PAGE; Leigh syndrome; NDUFS4; Next generation sequencing; Respiratory chain complex I

Mesh:

Substances:

Year:  2016        PMID: 27079373     DOI: 10.1016/j.mito.2016.04.001

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  18 in total

Review 1.  NDUFS6 related Leigh syndrome: a case report and review of the literature.

Authors:  Cécile Rouzier; Annabelle Chaussenot; Konstantina Fragaki; Valérie Serre; Samira Ait-El-Mkadem; Christian Richelme; Véronique Paquis-Flucklinger; Sylvie Bannwarth
Journal:  J Hum Genet       Date:  2019-04-04       Impact factor: 3.172

Review 2.  Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions.

Authors:  Maurizio Forte; Silvia Palmerio; Franca Bianchi; Massimo Volpe; Speranza Rubattu
Journal:  J Mol Med (Berl)       Date:  2019-03-12       Impact factor: 4.599

3.  The novel targets of DL-3-n-butylphthalide predicted by similarity ensemble approach in combination with molecular docking study.

Authors:  Yan Wang; Wei Qi; Li Zhang; Zhenguang Ying; Ou Sha; Chunman Li; Lanhai Lü; Xiangyan Chen; Zhenzhong Li; Feng Niu; Fang Xue; Dong Wang; Tzi-Bun Ng; Lihong Zhang
Journal:  Quant Imaging Med Surg       Date:  2017-10

4.  Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I Deficiency.

Authors:  Takashi K Ito; Chenhao Lu; Jacob Khan; Quy Nguyen; Heather Z Huang; Dayae Kim; James Phillips; Jo Tan; Yenna Lee; Tuyet Nguyen; Samy Khessib; Natalie Lim; Surapat Mekvanich; Joshua Oh; Victor V Pineda; Weirong Wang; Alessandro Bitto; Jonathan Y An; John F Morton; Mitsutoshi Setou; Warren C Ladiges; Matt Kaeberlein
Journal:  Front Genet       Date:  2017-09-01       Impact factor: 4.599

5.  Novel NDUFS4 gene mutation in an atypical late-onset mitochondrial form of multifocal dystonia.

Authors:  Celine Bris; Tiphaine Rouaud; Valerie Desquiret-Dumas; Naig Gueguen; David Goudenege; Magalie Barth; Dominique Bonneau; Patrizia Amati-Bonneau; Guy Lenaers; Pascal Reynier; Anne-Sophie Lebre; Vincent Procaccio
Journal:  Neurol Genet       Date:  2017-12-11

6.  AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome.

Authors:  I Di Meo; S Marchet; C Lamperti; M Zeviani; C Viscomi
Journal:  Gene Ther       Date:  2017-07-27       Impact factor: 5.250

7.  Defined neuronal populations drive fatal phenotype in a mouse model of Leigh syndrome.

Authors:  Irene Bolea; Alejandro Gella; Elisenda Sanz; Patricia Prada-Dacasa; Fabien Menardy; Angela M Bard; Pablo Machuca-Márquez; Abel Eraso-Pichot; Guillem Mòdol-Caballero; Xavier Navarro; Franck Kalume; Albert Quintana
Journal:  Elife       Date:  2019-08-12       Impact factor: 8.140

8.  Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial disease.

Authors:  Simon C Johnson; Ernst-Bernhard Kayser; Rebecca Bornstein; Julia Stokes; Alessandro Bitto; Kyung Yeon Park; Amanda Pan; Grace Sun; Daniel Raftery; Matt Kaeberlein; Margaret M Sedensky; Philip G Morgan
Journal:  Mol Genet Metab       Date:  2020-04-03       Impact factor: 4.204

9.  Loss of Mitochondrial Ndufs4 in Striatal Medium Spiny Neurons Mediates Progressive Motor Impairment in a Mouse Model of Leigh Syndrome.

Authors:  Byron Chen; Jessica Hui; Kelsey S Montgomery; Alejandro Gella; Irene Bolea; Elisenda Sanz; Richard D Palmiter; Albert Quintana
Journal:  Front Mol Neurosci       Date:  2017-08-24       Impact factor: 5.639

10.  Exploring mTOR inhibition as treatment for mitochondrial disease.

Authors:  Abigail Sage-Schwaede; Kristin Engelstad; Rachel Salazar; Angela Curcio; Alexander Khandji; James H Garvin; Darryl C De Vivo
Journal:  Ann Clin Transl Neurol       Date:  2019-08-06       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.